Surveillance non-directed bronchial lavage allows confident use of focused antibiotics in the management of ventilator-associated pneumonia

Journal of Infection

Volumn 60, Issue 5, 2010, Pages 397-399

  Felton, Tim ^a   Mount, Thomas ^b   Chadwick, Paul ^b   Ghrew, Murad ^c   Dark, Paul ^c  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b MANCHESTER UNIVERSITY NHS FOUNDATION TRUST   (United Kingdom)

^c SALFORD ROYAL NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PIPERACILLIN PLUS TAZOBACTAM; TIMENTIN;

ADULT; ANTIBIOTIC THERAPY; BACTERIAL COUNT; BACTERIUM CULTURE; CLINICAL ARTICLE; CLINICAL PULMONARY INFECTION SCORE; CONTROLLED STUDY; FEMALE; HAEMOPHILUS INFLUENZAE; HIGH RISK PATIENT; HUMAN; LENGTH OF STAY; LETTER; LUNG LAVAGE; MALE; MORTALITY; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; PRESCRIPTION; PSEUDOMONAS; QUANTITATIVE ANALYSIS; STAPHYLOCOCCUS AUREUS; SURVIVAL RATE; VENTILATED PATIENT; VENTILATOR ASSOCIATED PNEUMONIA;

ANTI-BACTERIAL AGENTS; BRONCHOALVEOLAR LAVAGE; BRONCHOALVEOLAR LAVAGE FLUID; CROSS INFECTION; FEMALE; HUMANS; INFECTION CONTROL; MALE; MIDDLE AGED; PNEUMONIA, VENTILATOR-ASSOCIATED; SENTINEL SURVEILLANCE;

EID: 77952672405     PISSN: 01634453     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jinf.2010.02.012     Document Type: Letter

References (12)

1. Nseir S., Deplanque X., Di Pompeo C., Diarra M., Roussell-Delvallez M., Durocher A. Risk factors for relapse of ventilator-associated pneumonia related to non-fermenting Gram negative bacilli: a case-control study. J Infect 2008, 56:319-325.
2. Iregui M., Ward S., Sherman G., Fraser V.J., Kollef M.H. Clinical importance of delays in the initiation of appropriate antibiotic treatment for ventilator-associated pneumonia. Chest 2002, 122(1):262-268.
3. Joffe A., Muscedere J., Marshall J., Su Y., Heyland D. The safety of targeted antibiotic therapy for ventilator-associated pneumonia: a multicenter observational study. J Crit Care 2008, 23:82-90.
4. Thomas J., Forrest A., Bhavani S. Pharmacodynamic evaluation of factors associated with the development of bacterial resistance in acutely ill patients during therapy. Antimicrob Agents Chemother 1998, 42:521-527.
5. Cardenosa Cendrero J.A., Sole-Violan J., Bordes Benitez A., Noguera Catalan J., Arroyo Fernandez J., Saavedra Santana P., et al. Role of different routes of tracheal colonization in the development of pneumonia in patients receiving mechanical ventilation. Chest 1999, 116(2):462-470.
6. Cook D., Mandell L. Endotracheal aspiration in the diagnosis of ventilator-associated pneumonia. Chest 2000, 117(4 Suppl. 2):195S-197S.
7. Campbell G.D. Blinded invasive diagnostic procedures in ventilator-associated pneumonia. Chest 2000, 117(4 Suppl. 2):207S-211S.
8. Pugin J., Auckenthaler R., Mili N., Janssens J.P., Lew P.D., Suter P.M. Diagnosis of ventilator-associated pneumonia by bacteriologic analysis of bronchoscopic and nonbronchoscopic " blind" bronchoalveolar lavage fluid. Am Rev Respir Dis 1991, 143(5 Pt 1):1121-1129.
9. A'Court C.H., Garrard C.S., Crook D., Bowler I., Conlon C., Peto T., et al. Microbiological lung surveillance in mechanically ventilated patients, using non-directed bronchial lavage and quantitative culture. Q J Med 1993, 86(10):635-648.
10. Chastre J., Fagon J.Y. Ventilator-associated pneumonia. Am J Respir Crit Care Med 2002, 165(7):867-903.
11. Masterton R.G., Galloway A., French G., Street M., Armstrong J., Brown E., et al. Guidelines for the management of hospital-acquired pneumonia in the UK: report of the working party on hospital-acquired pneumonia of the British Society for Antimicrobial Chemotherapy. J Antimicrob Chemother 2008, 62:5-34.
12. Boots R.J., Phillips G.E., George N., Faoagali J. Surveillance culture utility and safety using low-volume blind bronchoalveolar lavage in the diagnosis of ventilator-associated pneumonia. Respirology 2008, 13(1):87-96.